Seeing Is Believing

Currently out of the existing stock ratings of Steve Scala, 38 are a HOLD (29.46%), 90 are a BUY (69.77%), 1 are a SELL (0.78%).
Analyst Steve Scala, currently employed at TD COWEN, carries an average stock price target met ratio of 68.42% that have a potential upside of 33.66% achieved within 742 days.
Steve Scala’s has documented 262 price targets and ratings displayed on 17 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 22-Sep-2026.
Analyst best performing recommendations are on ELAN (ELANCO ANIMAL HEALTH).
The best stock recommendation documented was for ELAN (ELANCO ANIMAL HEALTH) at 4/22/2025. The price target of $12 was fulfilled within 15 days with a profit of $3.11 (34.98%) receiving and performance score of 23.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2026
$315
$52.18 (19.85%)
$265
24 days ago
(10-Sep-2026)
6/7 (85.71%)
$60 (23.53%)
115
Buy Since 12-Sep-2025
$303
$40.18 (15.29%)
$298
1 months 14 days ago
(20-Aug-2026)
2/11 (18.18%)
$41.17 (15.72%)
35
Buy Since 09-Dec-2021
$300
$37.18 (14.15%)
$295
1 months 17 days ago
(17-Aug-2026)
14/16 (87.5%)
$49.67 (19.84%)
506
Hold Since 13-Aug-2026
$300
$37.18 (14.15%)
1 months 21 days ago
(13-Aug-2026)
1/2 (50%)
$49.18 (19.61%)
115
Buy Since 23-Jan-2023
$260
$-2.82 (-1.07%)
$235
1 months 24 days ago
(10-Aug-2026)
9/9 (100%)
$12.03 (4.85%)
133
Which stock is Steve Scala most bullish on?
Which stock is Steve Scala most reserved on?
What Year was the first public recommendation made by Steve Scala?